60 related articles for article (PubMed ID: 20888763)
1. Synthesis and evaluation of bivalent, peptidomimetic antagonists of the αvβ3 integrins.
Li F; Jas GS; Qin G; Li K; Li Z
Bioorg Med Chem Lett; 2010 Nov; 20(22):6577-80. PubMed ID: 20888763
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor.
Burnett CA; Xie J; Quijano J; Shen Z; Hunter F; Bur M; Li KC; Danthi SN
Bioorg Med Chem; 2005 Jun; 13(11):3763-71. PubMed ID: 15863003
[TBL] [Abstract][Full Text] [Related]
3. Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.
Raboisson P; Manthey CL; Chaikin M; Lattanze J; Crysler C; Leonard K; Pan W; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2006 Jul; 41(7):847-61. PubMed ID: 16697080
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics.
Gentilucci L; Cardillo G; Spampinato S; Tolomelli A; Squassabia F; De Marco R; Bedini A; Baiula M; Belvisi L; Civera M
J Med Chem; 2010 Jan; 53(1):106-18. PubMed ID: 20055426
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biochemical evaluation of novel alpha V beta 3 integrin ligands.
Marugan JJ; Haslow KD; Crysler C
Bioorg Med Chem Lett; 2004 Sep; 14(17):4553-5. PubMed ID: 15357991
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and initial evaluation of novel, non-peptidic antagonists of the alpha(v)-integrins alpha(v)beta(3) and alpha(v)beta(5).
Letourneau JJ; Liu J; Ohlmeyer MH; Riviello C; Rong Y; Li H; Appell KC; Bansal S; Jacob B; Wong A; Webb ML
Bioorg Med Chem Lett; 2009 Jan; 19(2):352-5. PubMed ID: 19081719
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
McQuade P; Knight LC; Welch MJ
Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
[TBL] [Abstract][Full Text] [Related]
9. Discrete functional motifs reside within the cytoplasmic tail of alphaV integrin subunit.
Haas TA
Thromb Haemost; 2008 Jan; 99(1):96-107. PubMed ID: 18217140
[TBL] [Abstract][Full Text] [Related]
10. Human integrin alphavbeta5: homology modeling and ligand binding.
Marinelli L; Gottschalk KE; Meyer A; Novellino E; Kessler H
J Med Chem; 2004 Aug; 47(17):4166-77. PubMed ID: 15293989
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biochemical evaluation of a cyclic RGD oxorhenium complex as new ligand of alphaVbeta3 integrin.
Aufort M; Gonera M; Chaignon N; Le Clainche L; Dugave C
Eur J Med Chem; 2009 Sep; 44(9):3394-401. PubMed ID: 19303174
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
Vellon L; Menendez JA; Liu H; Lupu R
Differentiation; 2007 Nov; 75(9):819-30. PubMed ID: 17999741
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of non-peptide alpha(v)beta(3)/alpha(5)beta(1) integrin dual antagonists containing 5,6-dihydropyridin-2-one scaffolds.
Benfatti F; Cardillo G; Fabbroni S; Galzerano P; Gentilucci L; Juris R; Tolomelli A; Baiula M; Spartà A; Spampinato S
Bioorg Med Chem; 2007 Dec; 15(23):7380-90. PubMed ID: 17869121
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional ligands that target cells displaying the alpha v beta3 integrin.
Owen RM; Carlson CB; Xu J; Mowery P; Fasella E; Kiessling LL
Chembiochem; 2007 Jan; 8(1):68-82. PubMed ID: 17154219
[TBL] [Abstract][Full Text] [Related]
15. Discovery of diphenylmethanepropionic and dihydrostilbeneacetic acids as antagonists of the integrin alphavbeta3.
Nagarajan SR; Meyer JM; Miyashiro JM; Engleman VW; Freeman SK; Griggs DW; Klover JA; Nickols GA
Chem Biol Drug Des; 2006 Feb; 67(2):177-81. PubMed ID: 16492166
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies of a series of peptidomimetic ligands for alpha(4) beta(1) integrin on Jurkat T-leukemia cells.
Liu R; Peng L; Han H; Lam KS
Biopolymers; 2006; 84(6):595-604. PubMed ID: 17041919
[TBL] [Abstract][Full Text] [Related]
17. Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting.
Manzoni L; Belvisi L; Arosio D; Civera M; Pilkington-Miksa M; Potenza D; Caprini A; Araldi EM; Monferini E; Mancino M; Podestà F; Scolastico C
ChemMedChem; 2009 Apr; 4(4):615-32. PubMed ID: 19212960
[TBL] [Abstract][Full Text] [Related]
18. Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.
Zhou Y; Peng H; Ji Q; Qi J; Zhu Z; Yang C
Bioorg Med Chem Lett; 2006 Nov; 16(22):5878-82. PubMed ID: 16982193
[TBL] [Abstract][Full Text] [Related]
19. Interaction and functional association of protein disulfide isomerase with alphaVbeta3 integrin on endothelial cells.
Swiatkowska M; Szymański J; Padula G; Cierniewski CS
FEBS J; 2008 Apr; 275(8):1813-23. PubMed ID: 18331351
[TBL] [Abstract][Full Text] [Related]
20. Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonists.
Boys ML; Schretzman LA; Chandrakumar NS; Tollefson MB; Mohler SB; Downs VL; Penning TD; Russell MA; Wendt JA; Chen BB; Stenmark HG; Wu H; Spangler DP; Clare M; Desai BN; Khanna IK; Nguyen MN; Duffin T; Engleman VW; Finn MB; Freeman SK; Hanneke ML; Keene JL; Klover JA; Nickols GA; Nickols MA; Steininger CN; Westlin M; Westlin W; Yu YX; Wang Y; Dalton CR; Norring SA
Bioorg Med Chem Lett; 2006 Feb; 16(4):839-44. PubMed ID: 16298127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
